By Dr. Susan Lin, MD | MD HAIR | La Cañada Ventures, Inc.
I remember the appointments that changed the direction of my career, and they were never the dramatic ones.
They were the quiet ones. A patient — eight months pregnant, or six weeks postpartum, or two years into trying to conceive — would finish the visit she'd actually booked, gather her things, pause at the door, and say some version of the same sentence: “One more thing. My hair is falling out, and I don't know what to do.”
And I would have to give her the answer medicine had on the shelf, which was, for her, almost nothing. Minoxidil? Not while pregnant or nursing. Finasteride? Absolutely not — contraindicated in any woman who is or may become pregnant. Hormone therapy? Not indicated, or not wanted, or not safe for her. The honest clinical answer was: the pharmaceutical toolbox was not built for you.
I heard that door-handle question hundreds of times. Eventually I stopped hearing it as an aside and started hearing it for what it was: an enormous, underserved population asking medicine a question it kept declining to answer.
This essay is my answer — why I became a formulating physician, why I formulate drug-free, and what that phrase does and does not mean.
Where I Come From
Let me tell you who is writing this, because the label on a bottle should never be more confident than the person behind it.
I trained at Boston University School of Medicine through its accelerated B.A./M.D. program, supported along the way by an NIH Scholarship. I am board-certified in Obstetrics & Gynecology and in Anti-Aging Medicine through the American Academy of Anti-Aging Medicine (A4M) — a combination that turned out to matter enormously, because it put me at the intersection where women's hair loss actually happens: hormones, life stages, pregnancy, postpartum, perimenopause, menopause.
I have been a formulating physician since 2007–2008, when I began developing what became the MD® line. I am the named inventor on U.S. Patent No. 8,206,695, the patent behind MD Lash Factor®. I say that not as decoration but as a statement of accountability: most brands license a doctor's name — I put my own on the label. When my name is on the label, every formulation decision is one I have to be able to defend, in writing, to any physician or any patient who asks.
And after 35 years in medicine, the single most important thing I have learned about this field is not biochemical. It's this: “In 35 years of medicine, I've learned hair loss is never vanity — it's identity.” No one who has sat with a weeping patient holding a handful of shed hair ever calls it cosmetic again.
What I Saw in Practice
Obstetrics and gynecology is a front-row seat to female hair biology, because the hair follicle is exquisitely responsive to the hormonal chapters of a woman's life. I watched the same patterns repeat for decades:
- The postpartum mother, three months out, shedding in handfuls as her estrogen-extended growth phase released all at once — terrified something was seriously wrong, and unable to use the standard topical because she was nursing.
- The woman trying to conceive, whose thinning had a clear androgen-pattern signature, for whom finasteride was unthinkable — a 5-alpha-reductase inhibitor can harm the development of a male fetus, which is why women of childbearing potential are directed away from it entirely (Hirshburg et al., 2016).
- The pregnant patient with pre-existing thinning, told to simply stop everything for two years of pregnancy and nursing, and to watch her progress erode in the meantime.
- The perimenopausal patient with migraines with aura, or a clotting history, or an estrogen-receptor-positive breast cancer in her chart — for whom hormone therapy was contraindicated outright, a caution the Women's Health Initiative era made vivid for an entire generation of women and their physicians (Writing Group for the WHI, 2002).
- The woman who could take a pharmaceutical but chose not to — who had read the side-effect profiles, weighed them, and made an informed adult decision that deserved respect rather than a shrug.
Add these women together and you do not get an edge case. You get the center of the female hair-loss population. The pharmaceutical options were built around molecules first and patients second; the exclusion criteria fell where they fell, and an extraordinary number of women fell outside them.
Meanwhile, the psychological weight these patients carried was not soft or minor. The dermatology literature has documented for decades that hair loss carries a measurable psychological burden — anxiety, depression, social withdrawal, damaged self-concept (Cash, 2001). Identity, as I said. Not vanity.
So I faced a choice that many physicians face in some form: keep apologizing for the toolbox, or build a different one.
Why Drug-Free — The Formulation Philosophy
When I began formulating in 2007–2008, I made a decision that has governed everything since: the formulation would be drug-free and hormone-free, and suitability would come first.
Most formulation starts with the question “what is the most potent thing I can put in this bottle?” I inverted it: “what can the most excluded patient on my list reasonably consider, and how effective can I make it within that boundary?” Design for her, and you design for everyone.
That single inversion produces the whole MD HAIR philosophy:
1. Suitability first. Every ingredient is chosen so that the answer to “but can I use this?” is as simple as possible. Drug-free. Hormone-free. No systemic pharmaceutical mechanisms, no endocrine levers. And one boundary I state plainly rather than in fine print: because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation. Whatever you use, in any season of life, review it with your own physician. That is how medicine is supposed to work.
2. Mechanism-driven botanicals and peptides. Drug-free does not mean mechanism-free. I select actives the way I was trained to evaluate any intervention: identify the biological pathway — follicular microcirculation, the scalp's oxidative and inflammatory environment, the nutritional substrate of keratin synthesis, and the cells at the base of the follicle where the androgen signal lands — and choose defined molecules with published laboratory work relevant to them. Our lilac-derived verbascoside work, standardized through plant stem cell technology, is the clearest example: in laboratory studies on human dermal papilla cells, verbascoside prevented testosterone-induced cell death and reduced the release of pro-inflammatory signals. Those are cell studies, not human trials, and I've written about that science, and its limits, in depth elsewhere on this site.
3. Substantiation on file. Every claim we make is written down, sourced, and kept on file before it appears in our materials. Laboratory findings are described as laboratory findings. Consumer use study results are described as consumer use study results, with “individual results vary” attached — because it's true. I refuse to let marketing outrun evidence, and cosmetics and supplements never diagnose, treat, cure, or prevent disease. Full stop.
4. Made in FDA-registered, GMP facilities in the USA. Drug-free does not mean standards-free. Our products are manufactured in FDA-registered facilities operating under Good Manufacturing Practices, here in the United States. (Note the precise language: facilities are FDA-registered. No cosmetic or supplement is “FDA approved,” and any brand telling you otherwise has just told you everything you need to know about its relationship with accuracy.)
What Drug-Free Does Not Mean
This section may be the most important one in the essay, because “drug-free” is a phrase that gets abused in this industry, and I want no part of that.
Drug-free does not mean anti-medicine. I am a physician. I have prescribed pharmaceuticals my entire career and will defend their appropriate use without hesitation. Minoxidil has genuine evidence behind it. For the right patient, in consultation with her own doctor, it is a legitimate choice — and MD HAIR is designed to work with or without minoxidil, not to demand you renounce it. A scalp-care and internal-nutrition protocol and a pharmaceutical are not rivals; they address different parts of the follicle's world.
Drug-free does not mean “secretly better than drugs.” Our products are not drugs, and they do not do what drugs do. Drug-free means a different risk-and-suitability profile, honestly labeled, addressed to the same hair concern. I formulate for the enormous population that pharmaceuticals exclude or that chooses differently — I do not pretend botanicals are pharmaceuticals in disguise.
Drug-free does not mean you should skip your doctor. The opposite. Hair loss can be a signal — thyroid dysfunction, iron deficiency, hormonal disorders, autoimmune conditions. I say this in nearly every article I write: get the workup. Work with your own physician. Anything I formulate is meant to sit alongside good medical care, never in place of it.
And drug-free does not mean evidence-free. It means the evidence is stated at exactly its true weight — no more, no less. That discipline is, frankly, the entire brand.
The Bottom Line
I formulate drug-free because the women who most needed help were the women the pharmaceutical toolbox excluded: women with contraindications, women in seasons of life when the drugs must be set aside, women who made an informed choice to decline systemic drugs. Designing for them — suitability first, mechanisms second to none, substantiation on file, manufactured to GMP standards in FDA-registered U.S. facilities — produced something better than a compromise. It produced a protocol a woman can consider, with her physician, across the chapters of her life, with or without pharmaceuticals alongside it.
Most brands license a doctor's name. I put my own on the label. After 35 years in medicine, that still feels like the most honest sentence in this industry — and the standard I intend to keep answering to.
Dr. Susan Lin's Clinical Perspective
“People assume 'drug-free' is a marketing posture. For me it is a clinical triage decision. When the patients most in need of help are precisely the patients every pharmaceutical option excludes, the physician's obligation is to build something rigorous inside the boundary of what they can actually consider. That constraint made me a better formulator, not a softer one: every active has to earn its place on mechanism, every claim has to match its evidence, and every batch has to meet the standard my own name on the label demands. Drug-free is not the absence of medicine. Done honestly, it is medicine's discipline applied where medicine's molecules cannot go.”
— Dr. Susan Lin, MD, Physician Formulator, MD HAIR
Mechanism Spotlight: Why Drug-Free and Minoxidil Aren't Rivals
A question I'm asked constantly: “Do I have to choose?” No — and the reason is mechanistic. Minoxidil is understood to act primarily as a growth-phase stimulant: it helps push follicles toward and hold them in anagen. It does not meaningfully address the rest of the follicle's operating environment — the scalp's local androgen biology (Sawaya & Price, 1997), the oxidative and inflammatory microenvironment around the follicle, or the internal nutritional substrate the hair matrix draws on to build keratin. A drug-free protocol built on scalp preparation, cell-level botanical science, and internal nutrition works those other layers — without doing what the drug does, and without claiming to. The mechanisms are complementary, not competing — which is why MD HAIR is formulated to work with or without minoxidil, and why the right question isn't “which side are you on?” but “which layers of the follicle's environment are being addressed?” Decide the pharmaceutical question with your own physician; the environment around that decision is what I build for.
Recommended Reading
Pillar pages on mdhair.com:
Related articles in this series:
- Why Your Hair Is Falling Out in Your 40s — Perimenopause, estrogen decline, and the population of women for whom hormone therapy isn't an option
- Menopause and Hair Loss: The Complete Guide — What's happening to your hair after the transition, and what you can actually do about it
MD HAIR Product Recommendation
Start with the 60-Second Hair Quiz — Then the Complete Protocol
If this essay resonated, the right first step isn't a product — it's information. Take the 60-second hair quiz: it walks through your life stage, your pattern of thinning, and your suitability considerations, and points you to the right starting place.
For most women ready for the full drug-free protocol, that's the MD® Hair Restoration Kit — Scalp Essential + Follicle Energizer + Nutri Hair — scalp, follicle, and internal nutrition together, because those are the three layers of the follicle's environment this essay describes. It is the complete 3-step protocol, formulated drug-free and hormone-free to work with or without minoxidil. Individual results vary. Because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.
Learn more: MD® Hair Restoration Kit · Take the Hair Quiz
References
- Cash TF. (2001). The psychology of hair loss and its implications for patient care. Clinics in Dermatology, 19(2), 161–166.
- Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 288(3), 321–333.
- Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. (2016). Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): A systematic review. Journal of Clinical and Aesthetic Dermatology, 9(7), 56–62.
- Sawaya ME, Price VH. (1997). Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. Journal of Investigative Dermatology, 109(3), 296–300.
- Lin S. (2012). U.S. Patent No. 8,206,695: Eyelash enhancement composition and method of treatment. Washington, DC: U.S. Patent and Trademark Office.
Dr. Susan Lin, MD is the physician formulator behind MD HAIR, a line of drug-free, hormone-free, clinically informed hair care products by La Cañada Ventures, Inc. This article is for educational purposes and does not constitute medical advice. Consult your physician for personalized guidance. Because there are no clinical data in pregnant or breastfeeding women, we do not advocate using MD HAIR products during pregnancy or lactation.
MD HAIR products are cosmetics and dietary supplements. MD Nutri Hair™ is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.
Read more about the physician behind MD HAIR at mdhair.com/pages/dr-susan-lin-md